Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2008
10/23/2008CA2688693A1 Interferons of rhesus and cynomolgus origin and uses thereof
10/23/2008CA2684368A1 Secreted frizzled related protein 3 for use in the inhibition of scarring
10/23/2008CA2684042A1 Use of substrates as pharmacological chaperones
10/23/2008CA2683973A1 Sparc and methods of use thereof
10/23/2008CA2683890A1 Methods and compositions for contributing to the treatment of cancers
10/23/2008CA2683822A1 Calcium flux as a pharmacoefficacy biomarker for inhibitors of histone deacetylase
10/23/2008CA2683797A1 Means and methods for counteracting protein aggregation
10/23/2008CA2683603A1 Lyophilized pharmaceutical compositions and methods of making and using same
10/23/2008CA2683562A1 Sirtuin based methods and compositions for treating .beta.-catenin-related conditions
10/23/2008CA2683463A1 Anti-tumor drug, medicament, composition, and use thereof
10/23/2008CA2682730A1 Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
10/23/2008CA2663523A1 Novel gene disruptions, compositions and methods relating thereto
10/22/2008EP1983057A2 Improved AAV vectors for gene therapy
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1983054A1 Carbonic anhydrase and methods using the same
10/22/2008EP1983050A1 Peptides binding to the Lck-SH3 and Hck-SH3 domains
10/22/2008EP1983049A1 Peptides binding to the Lck-SH3 and Hck-SH3 domains
10/22/2008EP1982994A2 Carbohydrate-mimetic peptides and use thereof in pharmaceutical formulations
10/22/2008EP1982992A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector
10/22/2008EP1982990A1 Cytokine receptor common gamma chain like
10/22/2008EP1982732A2 Factor VII or VIIA-like molecules
10/22/2008EP1982725A1 Method or agent for inhibiting the function of efflux pump of pseudomonas aeruginosa
10/22/2008EP1982719A1 Treatment of hypertension in women receiving hormone replacement therapy
10/22/2008EP1982192A1 METHOD FOR ProNGF ASSAY FOR IN VITRO DIAGNOSIS OF CANCER IN PARTICULAR BREAST , THYROID AND LUNG CANCER AND THERAPEUTIC USE OF ProNGF
10/22/2008EP1982008A1 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration
10/22/2008EP1981974A2 Compositions and methods for treating lysosomal storage diseases
10/22/2008EP1981908A2 Novel fsh glycosylation variant d3n
10/22/2008EP1981903A1 Asparagine-10-substituted nonadepsipeptides
10/22/2008EP1981901A1 Amino acid derivatives
10/22/2008EP1981572A2 Pulmonary delivery of alpha-i proteinase inhibitor
10/22/2008EP1981531A2 Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases
10/22/2008EP1981530A2 Composition containing several botulic toxins
10/22/2008EP1981529A2 Colony stimulating factors for the treatment of coma and neurotoxicity
10/22/2008EP1981526A2 Adiponectin for treatment of various disorders
10/22/2008EP1981525A1 Extended release of neuregulin for improved cardiac function
10/22/2008EP1981524A2 Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto
10/22/2008EP1981523A2 Novel hcv inhibitor combinations and methods
10/22/2008EP1981522A2 Compositions and methods for enhancing neuronal plasticity and regeneration
10/22/2008EP1981521A2 Compositions and methods for inhibition leukocyte function
10/22/2008EP1981520A2 Combination therapy for the treatment of neovascular disorders
10/22/2008EP1981519A2 Protease inhibition
10/22/2008EP1981514A2 Biomimetic hydroxyapatite synthesis
10/22/2008EP1981503A2 Novel neurological function of mpkci
10/22/2008EP1981483A1 Technology for preparation of macromolecular microspheres
10/22/2008EP1981482A1 Process for preparing a particle comprising a biological molecule and a carrier polymer
10/22/2008EP1814902B1 Cyclosporine analogue
10/22/2008EP1778271B1 Peptides for the treatment of herpes virus infections
10/22/2008EP1677823B1 Botulinum toxin treatments of neurological and neuropsychiatric disorders
10/22/2008EP1560590B1 Synthetic complementary peptides and ophthalmologic uses thereof
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008EP1368371B1 Transfection complexes
10/22/2008EP1326631B2 Botulinumtoxin for treating endocrine disorders
10/22/2008EP1287364B1 Diagnostics and therapeutics for macular degeneration-related disorders
10/22/2008EP1266022B1 Cell-specific adenovirus vectors comprising an internal ribosome entry site
10/22/2008EP1235861B1 Transgenic mouse expressing steroid-activated nuclear receptor
10/22/2008EP1235590B1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
10/22/2008EP1054677B1 Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
10/22/2008EP1041888B1 Anti-retroviral immunogens, preparation and use
10/22/2008EP0833941B1 Polypeptides having a functional domain of interest and methods of identifying and using same
10/22/2008EP0787011B1 microemulsion preconcentrate comprising a macrolide
10/22/2008EP0746612B1 Synthetic polynucleotides
10/22/2008EP0742825B1 Cloning and recombinant production of crf receptor(s)
10/22/2008CN101291686A Activated factor X(FXa) stimulants as new antihemorrhagic agents for topical use
10/22/2008CN101291685A Exendin for treating diabetes and reducing body weight
10/22/2008CN101291684A Glycolated and glycosylated poultry derived therapeutic proteins
10/22/2008CN101291683A Methods and compositions for treating conditions
10/22/2008CN101289512A Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
10/22/2008CN101289507A Collagen protein and collagen polypeptides, preparation thereof and applications
10/22/2008CN101289505A Bone marrow regeneration regulatory protein BRRG-2, encoding gene thereof and uses thereof
10/22/2008CN101289504A Bone marrow regeneration regulatory protein BRRG-1, encoding gene thereof and uses thereof
10/22/2008CN101289501A Pokeweed antibiotic peptides, precursor peptides thereof, polynucleotide and applications
10/22/2008CN101289500A Long lasting fusion peptide inhibitor of viral infection
10/22/2008CN101289495A Selenium-containing pentapeptide compounds and uses thereof
10/22/2008CN101289494A Cyclic peptides with vasodilator action, preparation and uses thereof
10/22/2008CN101288769A Bactericide for pet and preparation method thereof
10/22/2008CN101288768A Medicine composition for treating progressive nerve degeneration disease
10/22/2008CN101288767A Chinese traditional medicine for control of recurrent respiratory tract infection and assisted-therapy of tumor and its preparation method
10/22/2008CN101288686A Health preparation for increasing bone density and preparation method thereof
10/22/2008CN100427503C Polypeptide in small molecule of endothelium inhibin, nucleotide sequence for encoding the polypeptide and complementary strand
10/22/2008CN100427502C Antineoplastic oligopeptide and its preparation method and application
10/22/2008CN100427141C Composition of SOD and animal medicine or its extractives, and its prepn. method
10/22/2008CN100427140C Freeze-drying powder injection of Bozhi glycopeptide and its preparation
10/22/2008CN100427139C Water-soluble shps as novel alkylating agents
10/22/2008CN100427077C Dry powder inhalation system for transpulmonary administration
10/21/2008US7439418 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide
10/21/2008US7439374 e.g. 4-[3-(Furo[3,2-c]pyridin-2-yl-carbonyl)-thioureido]-benzoic acid butyl ester; viricide; hepatitis C (HCV) infections, cirrhosis, end-stage liver disease, and liver cancer; side effects reducer
10/21/2008US7439347 Hepatitis C virus non-structural NS3/4A fusion gene
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439335 Synthetic antigen presenting matrix/biological scaffold comprising immobilized major histocompatibility complex for use in identifying modulator for treatment and prevention of autoimmune, allergy and cancer disorders
10/21/2008US7439333 Vascular endothelial growth factor 2
10/21/2008US7439331 Inhibition of complement activation
10/21/2008US7439329 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase
10/21/2008US7439327 Stem cell factor-like proteins and uses thereof
10/21/2008US7439325 PRO6001 polypeptides
10/21/2008US7439324 amyotrophic lateral sclerosis-specific epitope is conjugated to keyhole limpet hemocyanin; biodrug for eliciting immune response in animal to produce antibody; use in diagnosis, prognosis and therapeutic intervention in neurodegenerative Alzheimer's disease, Parkinson's disease, Huntington's disease
10/21/2008US7439323 Cysteine-containing peptides having antioxidant properties
10/21/2008US7439322 Nucleic acid; glycosylation
10/21/2008US7439321 Peptides for detection of antibody to Anaplasma phagocytophilum
10/21/2008US7439320 Cripto tumour polypeptide
10/21/2008US7439319 Selective substrates for matrix metalloproteinases
1 ... 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 ... 3163